Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #Daniel J. Tenney, Richard J. Colonno, Dong Xu et al.|Hepatology|2009Cited by 815
Entecavir resistance is rare in nucleoside naïve patients with hepatitis BRichard J. Colonno, Daniel J. Tenney, Cheng Fang Yu et al.|Hepatology|2006Cited by 348
Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions PresentDaniel J. Tenney, Richard J. Colonno, Ronald E. Rose et al.|Antimicrobial Agents and Chemotherapy|2006Cited by 239
A Novel Small Molecule Inhibitor of Hepatitis C Virus EntryCarl J. Baldick, Daniel J. Tenney, Michael Wichroski et al.|PLoS Pathogens|2010Cited by 82
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic responseCarl J. Baldick, Richard J. Colonno, Betsy J. Eggers et al.|Journal of Hepatology|2008Cited by 68